Literature DB >> 7344110

Field trial of praziquantel in human opisthorchiasis in Thailand.

S Supanvanich, K Supanvanich, P Pawabut.   

Abstract

Praziquantel is an excellent drug for treatment against Opisthorchis viverrini infection. Sixty cases of Opisthorchis viverrini infection were treated with Praziquantel, 3 x 25 mg/kg body weight for one day, except one case that was retreated with the same regimen at one month after the first treatment, and the cure rate was 100.0% at one year after the treatment. The side effects of the drug were headache, lassitude, sleepiness, and diarrhoea, but most of these were only in mild degree. Other laboratory findings showed no abnormal changes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7344110

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment.

Authors:  T Boonmars; P Srirach; B Kaewsamut; T Srisawangwong; S Pinlaor; P Pinlaor; P Yongvanit; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-12-06       Impact factor: 2.289

2.  Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel.

Authors:  T Boonmars; T Srisawangwong; P Srirach; B Kaewsamut; S Pinlaor; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-09-13       Impact factor: 2.289

3.  A characteristic immunoblotting pattern for Opisthorchiasis sera with metacercarial antigens.

Authors:  S Tanvanich; G Doungchawee; S Boonpucknavig; W Thamavit
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

4.  Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.

Authors:  Leonore Lovis; Tippi K Mak; Khampheng Phongluxa; Phonepasong Ayé Soukhathammavong; Youthanavanh Vonghachack; Jennifer Keiser; Penelope Vounatsou; Marcel Tanner; Christoph Hatz; Jürg Utzinger; Peter Odermatt; Kongsap Akkhavong
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.